Waldencast plc (MLKMF)

Market Cap	90.73M -56.5%
Revenue (ttm)	237.32M -13.6%
Net Income	-166.64M
EPS	-1.42
Shares Out	119.37M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	131,174
Open	0.8100
Previous Close	0.7500
Day's Range	0.6500 - 0.8500
52-Week Range	0.6500 - 3.2200
Beta	0.01
Analysts	Buy
Price Target	2.05 (+169.7%)
Est. Earnings	Nov 20, 2026

About Waldencast

Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products. In addition, the company provides foundation, concealer, primer, blush, setting spray, and bronzer categories, as w...

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2020
• Employees: 367
• Stock Exchange: OTCMKTS
• Ticker Symbol: MLKMF

Financial Performance

In 2025, Waldencast's revenue was $272.07 million, a decrease of -0.66% compared to the previous year's $273.87 million. Losses were -$229.75 million, 441.3% more than in 2024.

Analyst Summary

According to 2 analysts, the average rating for MLKMF stock is "Buy." The 12-month stock price target is $2.05, which is an increase of 169.70% from the latest price.

Price Target

$2.05

(169.70% upside)

Analyst Consensus: Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 13, 2026

Data Sources Report a data error